Search Contract Opportunities

Request for Information for FDA Contact Center Optimization   2

ID: FDA-RFI-2026-131159 • Type: Sources Sought • Match:  85%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Draft a sources sought response template for this opportunity
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Posted: Nov. 6, 2025, 11:52 a.m. EST

Amendment 3 is to clarify that the correct RFI number is FDA-RFI- 2026- 131159.

Amendment 2 is being posted on 10/31/2025 for the following purposes:

1) To provide responses to the questions that FDA received.

2) To update RFI response due date to Monday, November 10, 2025, at 5:00 PM Eastern Time.

Amendment 1 is posted on 10/22/2025 for the following purposes: 1) RFI response due date is now extended until further notice. and 2) Industry Day/Follow-up time is now to be determined (TBD).

The purpose of this Request for Information (RFI) is to gain a better understanding of, and potentially
leverage, current and emerging industry capabilities to modernize FDA's technology and service for
information flow into and through the FDA. More specifically, FDA aims to gather insights from industry
on solutions to achieve a modern, integrated, and secure approach to unified inquiry intake and
information flow. To this end, FDA is seeking innovative approaches to contact centers and help desks.

Posted: Oct. 31, 2025, 2:37 p.m. EDT
Posted: Oct. 22, 2025, 4:12 p.m. EDT
Posted: Oct. 6, 2025, 5:08 p.m. EDT
Background
The U.S. Food & Drug Administration (FDA) is seeking to modernize its technology and services for information flow into and through the agency. The goal of this Request for Information (RFI) is to gather insights from industry on innovative approaches to contact centers and help desks, aiming for a modern, integrated, and secure inquiry intake system.

The FDA's mission-critical operations have been hindered by a fragmented process and technology environment, leading to inefficiencies and a poor customer experience. This RFI is part of FDA's efforts to eliminate information silos and improve service delivery as per executive orders focused on enhancing public trust and operational efficiency.

Work Details
The scope includes developing a structured tiered contact center and enterprise CRM system to support inquiries and complaints raised to the FDA. Key tasks include:
- Tier 0 (Self-Service): Update operational governance for digital content, consolidate inquiry intake forms, improve search functionality on the FDA website, and enhance self-service resources such as FAQs and video tutorials.
- Tier 1-3: Establish an enterprise Tier 1 call center, triage contacts at all stages, define scripts for calls, ensure consistent use of the Automated Call Distribution system across all centers, maintain specialized knowledge among staff for Tier 2 and 3 calls.
- Enterprise CRM solution: Implement comprehensive case management, customer relationship management, and tiered support structure with escalation management.
- Performance Monitoring: Develop metrics for tracking performance metrics across tiers, ensuring quality assurance in service delivery.

Place of Performance
The work will be performed at various locations as determined by the FDA's operational needs.

Overview

Response Deadline
Nov. 10, 2025, 5:00 p.m. EST (original: Oct. 27, 2025, 5:00 p.m. EDT) Past Due
Posted
Oct. 6, 2025, 5:08 p.m. EDT (updated: Nov. 6, 2025, 11:52 a.m. EST)
Set Aside
None
NAICS
None
PSC
None
Place of Performance
Silver Spring, MD 20993 United States
Source

Est. Level of Competition
Average
Odds of Award
29%
On 10/6/25 Food and Drug Administration issued Sources Sought FDA-RFI-2026-131159 for Request for Information for FDA Contact Center Optimization due 11/10/25.
Primary Contact
Name
Min Jie Zeng   Profile
Phone
None

Secondary Contact

Name
Lilibeth Deato   Profile
Phone
None

Documents

Posted documents for Sources Sought FDA-RFI-2026-131159

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Sources Sought FDA-RFI-2026-131159

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Sources Sought FDA-RFI-2026-131159

Similar Active Opportunities

Open contract opportunities similar to Sources Sought FDA-RFI-2026-131159

Experts for Request for Information for FDA Contact Center Optimization

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA OFFICE OF ACQ GRANT SVCS
FPDS Organization Code
7524-00223
Source Organization Code
100188033
Last Updated
Nov. 25, 2025
Last Updated By
minjie.zeng@fda.hhs.gov
Archive Date
Nov. 25, 2025